Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Kenney-Jung

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Child Neurology|September 23, 2016
NeuroDebian Virtual Machine Deployment Facilitates Trainee-Driven Bedside Neuroimaging ResearchAlexander Cohen, Daniel Kenney-Jung, Hugo Botha, et al.
The American Journal of Case Reports|January 5, 2021
Endovascular Therapy for Childhood Ischemic StrokeMalik Ghannam, Lara Zakarna, Issa Alawneh, et al.
Annals of Clinical and Translational Neurology|September 7, 2019
Segmentation errors and intertest reliability in automated and manually traced hippocampal volumesBenjamin H Brinkmann, Hari Guragain, Daniel Kenney-Jung, et al.
JIMD Reports|November 15, 2024
Gaucher disease type 3c: Expanding the clinical spectrum of an ultra-rare diseaseJohn S Wang, Rebecca L Koch, Daniel Kenney-Jung, et al.
Neurology|January 26, 2018
Spatial variation in high-frequency oscillation rates and amplitudes in intracranial EEGHari Guragain, Jan Cimbalnik, Matt Stead, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 19, 2022
Reply to "Prophylactic Allogeneic Hematopoietic Stem Cell Therapy for CSF1R-Related Leukoencephalopathy"Philip W Tipton, Daniel Kenney-Jung, Beth K Rush, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 30, 2021
Treatment of CSF1R-Related Leukoencephalopathy: Breaking New GroundPhilip W Tipton, Daniel Kenney-Jung, Beth K Rush, et al.
Ebiomedicine|January 3, 2026
Plasma glial fibrillary acidic protein (GFAP) is a biomarker for central nervous system involvement in infantile-onset Pompe diseaseNeha Regmi, Bijan Abar, Jeong-A Lim, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 27, 2025
Infantile-onset Pompe disease entering adulthood: Insights from 2 decades of enzyme replacement therapy experienceNeha Regmi, Daniel Kenney-Jung, Grace Stafford, et al.
American Journal of Medical Genetics. Part A|May 11, 2019
A report on state-wide implementation of newborn screening for X-linked AdrenoleukodystrophyKatie Wiens, Susan A Berry, Hyoung Choi, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Child Neurology|September 23, 2016
NeuroDebian Virtual Machine Deployment Facilitates Trainee-Driven Bedside Neuroimaging ResearchAlexander Cohen, Daniel Kenney-Jung, Hugo Botha, et al.
The American Journal of Case Reports|January 5, 2021
Endovascular Therapy for Childhood Ischemic StrokeMalik Ghannam, Lara Zakarna, Issa Alawneh, et al.
Annals of Clinical and Translational Neurology|September 7, 2019
Segmentation errors and intertest reliability in automated and manually traced hippocampal volumesBenjamin H Brinkmann, Hari Guragain, Daniel Kenney-Jung, et al.
JIMD Reports|November 15, 2024
Gaucher disease type 3c: Expanding the clinical spectrum of an ultra-rare diseaseJohn S Wang, Rebecca L Koch, Daniel Kenney-Jung, et al.
Neurology|January 26, 2018
Spatial variation in high-frequency oscillation rates and amplitudes in intracranial EEGHari Guragain, Jan Cimbalnik, Matt Stead, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 19, 2022
Reply to "Prophylactic Allogeneic Hematopoietic Stem Cell Therapy for CSF1R-Related Leukoencephalopathy"Philip W Tipton, Daniel Kenney-Jung, Beth K Rush, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 30, 2021
Treatment of CSF1R-Related Leukoencephalopathy: Breaking New GroundPhilip W Tipton, Daniel Kenney-Jung, Beth K Rush, et al.
Ebiomedicine|January 3, 2026
Plasma glial fibrillary acidic protein (GFAP) is a biomarker for central nervous system involvement in infantile-onset Pompe diseaseNeha Regmi, Bijan Abar, Jeong-A Lim, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 27, 2025
Infantile-onset Pompe disease entering adulthood: Insights from 2 decades of enzyme replacement therapy experienceNeha Regmi, Daniel Kenney-Jung, Grace Stafford, et al.
American Journal of Medical Genetics. Part A|May 11, 2019
A report on state-wide implementation of newborn screening for X-linked AdrenoleukodystrophyKatie Wiens, Susan A Berry, Hyoung Choi, et al.
Pageof 2